CN1912621A - Chemiluminescence investigating method of triglyceride in serum - Google Patents
Chemiluminescence investigating method of triglyceride in serum Download PDFInfo
- Publication number
- CN1912621A CN1912621A CN 200610114972 CN200610114972A CN1912621A CN 1912621 A CN1912621 A CN 1912621A CN 200610114972 CN200610114972 CN 200610114972 CN 200610114972 A CN200610114972 A CN 200610114972A CN 1912621 A CN1912621 A CN 1912621A
- Authority
- CN
- China
- Prior art keywords
- triglyceride
- serum
- light signal
- concentration
- chemiluminescence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
A method for determining triglyceride in serum by utilizing chemiluminescence includes hydrolyzing TG by lipoprotein lipase to produce glycerol and fatty acid, using chemical to oxidize 3-phosphoglycerol to generate perhydrol, acting perhydrol by peroxidase to make chemiluminecent matter be oxidized for lightening, making light signal be more stronger when triglyceride concentration is more greater, using known concentration of triglyceride and measured light signal to work out dosage-reaction curve for calculating out triglyceride content in unknown sample by utilizing said curve.
Description
Technical field: the present invention relates to a kind of medical agent detection method, particularly the chemical luminescent detecting method of triglyceride in the serum.
Background technology: the ultramicro-determination method of utilizing modern biotechnology to develop has promoted the fast development of the every clinical and research work in biological and each field of medical science, greatly for outstanding contribution has been made in the mankind's cause of science and social progress.
Last century, the seventies was at first delivered the application luminol by Arakawa---the chemiluminescence reaction of peroxidase is carried out the technology that enzyme exempts to analyze, this technology since sensitivity up to 10
-18Mol can fast measuring go out the result in 20 minutes, can easy realization full automation, be valid up to more than 1 year, and "dead" and teratogen is beneficial to environmental protection and is well received, and is the detection technique the most rapidly of development at present.
At present, chemiluminescence has obtained quite universal degree in immunoassay, developed into the routine prison bed detection method that can detect multiple bioactivator, from immune response mode branch, this method has two kinds of fundamental types, be chemiluminescence immune assay (chemiluminescence immunoassay, CLIA) and immunochemiluminometry (Immunochemiluminometricassay, ICMA); From illumination mode, the one, with the direct mark of luminescent substance on antibody or antigen, after the immune response, and luminous, another kind is with enzymic-labelled antibody or antigen under the effect of incipient reagent, after the immune response, add chemical luminous substrate, under the enzyme caloytic action and luminous.
Though this method has outstanding advantage, only limit to immunoassay at present, and still blank in biochemical analysis.
Triglyceride (TG) is present in the blood, and hypertriglyceridemia is one of main performance of coronary heart disease.High TG under the pathological state has two classes of former and secondary.Primary has inherent cause more; Secondary cases sees diabetes, glycogenic thesaurismosis, thyroid function deficiency, nephrotic syndrome, gestation etc.
The method of triglyceride is the GPO-PAP colourimetry in the mensuration serum that now generally uses, this method is with lipoprotein lipase (LPL) TG to be hydrolyzed into glycerine and fatty acid, use glycerokinase (GK) and atriphos (ATP) that phosphoglycerol is changed into glycerol 3-phosphate (G-3-P) again, the latter is by GPO (GPO) oxidation, and generation hydrogen peroxide, again through the effect of superoxide enzyme, make look source thing (PAP) colour developing, TG content becomes positive correlation in absorbance and the sample, can carry out colorimetric estimation.The weak point of this method mainly contains:
1, the range of linearity is narrow.Owing to detect light absorption, its resolution is so responsive unlike chemiluminescence, and the range of linearity can not satisfy the needs of clinical detection fully, need measure after diluting the sample of high concentration, brings certain inconvenience.
2, sensitivity is not as chemiluminescence.Chemiluminescence is to measure light signal, and sensitivity absorbs high than photometry.
3, reagent composition complexity is operated loaded down with trivial detailsly, causes error easily, influences the accuracy of measurement result.
Summary of the invention: technical matters to be solved by this invention is a kind of chemical luminescent detecting method that can overcome triglyceride in above-mentioned defective, highly sensitive, the serum that the range of linearity is wide, convenient, safe that provides.Solve this technical problem the main technical schemes of employing: the chemical luminescent detecting method of triglyceride in the serum is characterized in that with lipoprotein lipase (LPL) TG being hydrolyzed into glycerine and fatty acid; Use glycerokinase (GK) and atriphos (ATP) that phosphoglycerol is changed into glycerol 3-phosphate (G-3-P) again; Glycerol 3-phosphate (G-3-P) is by GPO (GPO) oxidation, and the generation hydrogen peroxide; Through the effect of superoxide enzyme, hydrogen peroxide makes the chemiluminescent substance oxidation and is luminous again; The size of light signal and the concentration of serum triglyceride are proportionate, and promptly the big more light signal that sends of serum triglyceride concentration is strong more; Write down this light signal and can infer the concentration of serum triglyceride; With the triglyceride of concentration known and the light signal of measuring, make dose-response curve; The content of triglyceride of unknown sample can come out from this curve calculating; Described chemiluminescent substance is a luminol.The present invention compared with prior art has following advantage: replace the colour developing thing with chemiluminescent substance, reach sensitiveer, more stable, wide ranges, safer purpose.The commercially available reagent box that can prepare corresponding quantitative measurement serum triglyceride with this method.Concrete advantage is: 1. sensitivity is higher.Classic method is to detect shade, and chemiluminescence is the photometry signal, photon counting one by one, and the minimum of being surveyed is littler, thereby sensitivity is higher.2. the range of linearity is wide.The resolution of the depth of survey color is more much lower than the precision of photon counting, and chemiluminescent sensing range is up to 10
53. safe and applicable.Chemiluminescent substance such as luminol etc. are very safe, and whole testing process does not have nuisance and occurs, and are that detection or processing of waste are all very safe, help environmental protection.4. be convenient to popularize.The kit that the present invention is prepared can be used for all automatic measurement, also can be used for craft or semi-automatic measuring, and the medical treatment of suitable large, medium and small each level and research institution use.5. huge social benefit.With chemiluminescence determination biochemical indicator or immune substance, can no longer need the biochemical instruments of import costliness together with a Chemiluminescence Apparatus, save substantial contribution, not only reduced cost, medical institutions, patient and society are all benefited.
Embodiment: now illustrate embodiments of the invention.(LPL) is hydrolyzed into glycerine and fatty acid with TG with lipoprotein lipase; Use glycerokinase (GK) and atriphos (ATP) that phosphoglycerol is changed into glycerol 3-phosphate (G-3-P) again; Glycerol 3-phosphate (G-3-P) is by GPO (GPO) oxidation, and the generation hydrogen peroxide; Through the effect of superoxide enzyme, hydrogen peroxide makes the chemiluminescent substance oxidation and is luminous again; The size of light signal and the concentration of serum triglyceride are proportionate, and promptly the big more light signal that sends of serum triglyceride concentration is strong more; Write down this light signal and can infer the concentration of serum triglyceride; With the triglyceride of concentration known and the light signal of measuring, make dose-response curve; The content of triglyceride of unknown sample can come out from this curve calculating; Described chemiluminescent substance is a luminol; This is the chemical luminescent detecting method of triglyceride in the serum of the present invention.This method can be used for measuring the content of the triglyceride (TG) in the serum.
One, reagent comprises:
Mixed enzyme solution;
Triglyceride (or substitute) standard: single or series concentration;
Substrate solution
Two, mensuration program:
According to the form below carries out, and application of sample unit is μ l.
| Standard | Sample | |
| Standard | 10 | |
| Sample | 10 | |
| Enzyme liquid | 50 | 50 |
| Substrate solution | 50 | 50 |
| Mixing, measure R LU behind room temperature or the 37 ℃ of incubations | ||
Three, make dose-response curve with the proper method processing, RLU value is per sample obtained the concentration of its serum triglyceride from this curve.Or directly obtain by formula:
Triglyceride concentration=(sample RLU/ standard RLU) * normal concentration
Four, also available double reagent is measured.
Sensitivity of the present invention is higher: because classic method is to detect shade, and the present invention is the photometry signal, photon counting one by one, and the minimum of being surveyed is littler, thereby sensitivity is higher.The range of linearity is wide: this is that chemiluminescence detection scope of the present invention is up to 10 because the resolution of the depth of traditional survey color is more much lower than the precision of photon counting
5Safe and applicable: chemiluminescent substance of the present invention such as luminol etc. are very safe, and whole testing process does not have nuisance and occurs, and are that detection or processing of waste are all very safe, help environmental protection.Be convenient to popularize: the kit that the present invention is prepared, can be used for all automatic measurement, also can be used for craft or semi-automatic measuring, the medical treatment of suitable large, medium and small each level and research institution use.Social benefit is huge: measure biochemical indicator or immune substance with chemical luminescent detecting method of the present invention, can no longer need the biochemical instruments of import costliness together with a Chemiluminescence Apparatus, save substantial contribution, not only reduced cost, medical institutions, patient and society have all been benefited.The inventive method is simple, and cost is low, is suitable for large, medium and small medical institutions wide popularization and application.
Claims (2)
- The chemical luminescent detecting method of triglyceride in 1 serum is characterized in that with lipoprotein lipase (LPL) TG being hydrolyzed into glycerine and fatty acid; Use glycerokinase (GK) and atriphos (ATP) that phosphoglycerol is changed into glycerol 3-phosphate (G-3-P) again; Glycerol 3-phosphate (G-3-P) is by GPO (GPO) oxidation, and the generation hydrogen peroxide; Through the effect of superoxide enzyme, hydrogen peroxide makes the chemiluminescent substance oxidation and is luminous again; The size of light signal and the concentration of serum triglyceride are proportionate, and promptly the big more light signal that sends of serum triglyceride concentration is strong more; Write down this light signal and can infer the concentration of serum triglyceride; With the triglyceride of concentration known and the light signal of measuring, make dose-response curve; The content of triglyceride of unknown sample can come out from this curve calculating.
- The chemical luminescent detecting method of triglyceride in 2 serum according to claim 1 is characterized in that described chemiluminescent substance is a luminol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610114972 CN1912621A (en) | 2006-08-10 | 2006-08-10 | Chemiluminescence investigating method of triglyceride in serum |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610114972 CN1912621A (en) | 2006-08-10 | 2006-08-10 | Chemiluminescence investigating method of triglyceride in serum |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1912621A true CN1912621A (en) | 2007-02-14 |
Family
ID=37721610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200610114972 Pending CN1912621A (en) | 2006-08-10 | 2006-08-10 | Chemiluminescence investigating method of triglyceride in serum |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1912621A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101819154A (en) * | 2010-03-02 | 2010-09-01 | 苏州市玮琪生物科技有限公司 | Chromatography type triglyceride self-measuring system |
| CN102706818A (en) * | 2012-06-05 | 2012-10-03 | 宁波美康生物科技股份有限公司 | Enzymatic triglyceride measuring method and measuring reagent |
-
2006
- 2006-08-10 CN CN 200610114972 patent/CN1912621A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101819154A (en) * | 2010-03-02 | 2010-09-01 | 苏州市玮琪生物科技有限公司 | Chromatography type triglyceride self-measuring system |
| CN102706818A (en) * | 2012-06-05 | 2012-10-03 | 宁波美康生物科技股份有限公司 | Enzymatic triglyceride measuring method and measuring reagent |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Savigny et al. | The communication of ELISA data from laboratory to clinician | |
| Gyure | Comparison of several methods for semiquantitative determination of urinary protein. | |
| CN1912594A (en) | Chemiluminescence investigating method of creatinine in serum | |
| CN102866249B (en) | Tetramethylbenzidine (TMB) developing system | |
| CN104297468B (en) | The calibration steps of a kind of immune fetch equipment and this equipment | |
| CN101914611A (en) | Kit and method for clinical detection of myeloperoxidase | |
| CN1912622A (en) | Chemiluminescence investigating method of glucose in body fluid | |
| CN101059447A (en) | Method for analyzing protein nitrogen content of milk powder | |
| CN101639446A (en) | Method for detecting blood lactic acid in vitro by using chemiluminescence method | |
| CN1912589A (en) | Chemiluminescence measuring method of urea in serum | |
| CN1908628A (en) | Chemical luminescent detecting method of creatine kinase isozyme in serum | |
| Matteucci et al. | Point-of-care testing in diabetes care | |
| CN1912621A (en) | Chemiluminescence investigating method of triglyceride in serum | |
| CN101639445A (en) | Method for detecting blood pyruvate in vitro by using chemiluminescence method | |
| CN1912595A (en) | Chemiluminescence investigating method of serum total cholesterol in blood | |
| CN101071105A (en) | Method for determining glucose and 1,5-anhydroglucitol in identicial colorimetric cell | |
| CN109884317B (en) | Application of oxidized thio-coenzyme I in homogeneous enzyme immunodiagnosis reagent | |
| Oka et al. | Simultaneous fluorometry of urinary dopamine, norepinephrine, and epinephrine compared with liquid chromatography with electrochemical detection. | |
| Hedayati et al. | Rapid acid digestion and simple microplate method for milk iodine determination | |
| CN1908631A (en) | Chemical luminescent detecting method of lipase in serum | |
| CN1912591A (en) | Chemiluminescence measuring method of alpha-L-fucosidase in body fluid | |
| CN1912599A (en) | Chemiluminescence investigating method of uric acid in serum | |
| CN1912623A (en) | Chemiluminescence investigating method of plasma ammonia | |
| CN1912593A (en) | Chemiluminescence investigating method of serum monoamine oxidase in serum | |
| CN107356544A (en) | A kind of fatty enzyme detection kit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |